Title of Invention

"PREPARATION OF NON- CRYSTALLINE ATORVASTATIN CALCIUM"

Abstract Atorvastatin calcium, the substance known by the chemical name [(R-(R*,R*)]-2-(4-fluorophenyl)-b,ddihydorxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt is known as HMG-CoA reductase inhibitor and is used as an antihypercholesterolemic agent. Atorvastatin is usually prepared as its calcium salt since it enable atorvastatin to be conveniently formulated in the pharmaceutical formulations, for example, in tablets, capsules, powders and the like for oral administration. Atorvastatin calcium can exist in an amorphous form or in one of the crystalline forms (Form I, Form II, Form III and Form IV). Atorvastating calcium is the substance which is very slightly water-soluble, and it has been fou...
Full Text NA

Documents:

http://ipindiaonline.gov.in/documents/1132-DELNP-2003/1132-delnp-2003-form-1.pdf


Patent Number 231917
Indian Patent Application Number 1132/DELNP/2003
PG Journal Number 13/2009
Publication Date 27-Mar-2009
Grant Date 13-Mar-2009
Date of Filing 18-Jul-2003
Name of Patentee LEK PHARMACEUTICAL AND CHEMICAL COMPANY D.D.
Applicant Address VEROVSKOVA 57, 1526 LJUBLJANA, SLOVENIA
Inventors:
# Inventor's Name Inventor's Address
1 GORAZD SORSAK LACKOVA 5, 2325 KIDRICEVO/SLOVENIA
PCT International Classification Number C07D 207/34
PCT International Application Number PCT/IB02/00161
PCT International Filing date 2002-01-22
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 NA